WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m.

WuXi Biologics announced to sell its 15,520-square-meter, three-story vaccine manufacturing plant in Dundalk, Ireland for half a billion dollars. Photo: wuxi biologics/Reuters ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million, ahead of potential U.S. legislation that would restrict ...

DUNDALK, Ireland, June 16, 2025 /PRNewswire/ -- WuXi Biologics (2269), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its Ireland site has ...

At WuXi Biologics' state-of-the-art facility in Dundalk, Ireland, these priorities are no longer aspirational - they're operational.

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced major accomplishments at its cutting-edge greenfield ...

MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and expanding its vaccine production capabilities.